Dräger today announced the first implementations of its new Infinity® M300 patient-worn monitor. The new telemetry system has been installed at major hospitals in the United States and in Germany.
Infinity M300 provides the performance of a full-size patient monitor, packaged in a compact patient-worn telemetry device for adult and pediatric patients. This new design supports hospitals in their initiatives to mobilize patients as early as possible in order to accelerate the healing process.
In addition to monitoring ECG and SpO2, the device has built-in algorithms to enhance ECG processing and reduce false alarms – such as pacer detection software and ACE® (Arrhythmia Classification Expert), an arrhythmia analysis tool.
Infinity M300 can run on a hospital’s existing 802.11 b/g network – saving the expense of requiring a separate wireless network for the telemetry system. Infinity M300 addresses the three major challenges of telemetry monitoring. The first is viewing patient information at the patient’s side. Unlike traditional telemetry devices which have no screen, Infinity M300 has a color display that shows the patient’s ECG for all monitored leads, heart rate, SpO2, and electrode status – enabling the clinical staff to access monitored data and react promptly without having to go to the central monitoring station. The display also shows patient demographics to help confirm the patient’s identification before giving medication, taking blood samples, or performing treatments.
The second telemetry challenge is hearing and responding to alarms. Infinity M300 has built-in alarming and alarm controls, which provide alarm alerts both at the patient’s side and the Infinity CentralStation, Dräger’s central monitoring workstation. The built-in display helps the clinician assess alarms and respond accordingly.
The third challenge of telemetry monitoring is the cost and effort associated with disposable batteries. Infinity M300 has a built-in battery, which can be recharged via a bedside charger while the patient is wearing the device, or at a multi-device charger at the central monitoring station.
“Infinity M300 represents a major innovation in telemetry monitoring. We’re very excited about the system’s potential to help address the challenges of today’s busy ambulatory environments,” said Dina LaTulippe, Director of Product Management, Central Monitoring Solutions at Monitoring, Systems & IT in Andover, Massachusetts, USA. “Because Infinity M300 has a built-in display and alarms, it enables the clinical staff to be alerted to patient conditions without having to use additional devices.”
Founded in 1889, Drägerwerk AG & Co. KGaA is an international leader in the fields of medical and safety technology. Dräger products protect, support and save human life. In 2007, the Group achieved sales of €1,819.5 million worldwide and an EBIT of €151.9 million. Today, Dräger employs around 10,000 people in more than 70 subsidiaries worldwide and has representation in around 190 countries. The Dräger Medical subsidiary offers products, services and integrated system solutions which accompany the patient throughout the care process – Emergency Care, Perioperative Care, Critical Care or Perinatal care and Home Mechanical Ventilation.Contact for Trade Press
Burkard Dillig | Drägerwerk AG & Co. KGaA
Visualizing gene expression with MRI
23.12.2016 | California Institute of Technology
Illuminating cancer: Researchers invent a pH threshold sensor to improve cancer surgery
21.12.2016 | UT Southwestern Medical Center
A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...
For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.
According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
24.01.2017 | Physics and Astronomy
24.01.2017 | Life Sciences
24.01.2017 | Health and Medicine